China on Tuesday suspended visas for South Koreans to enter the country for tourism or business in apparent retaliation for South Korea’s COVID-19 testing requirements for Chinese travelers, the Associated Press Read more
Tag: specialized drugs
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5 billion in sales in 2023. Read more
China Approves Merck’s Molnupiravir for Emergency Use, Regulator Says
China’s top drug regulator said Friday that it approved Merck & Co.’s Molnupiravir for emergency use on Thursday, as the country grapples with waves of infections after Beijing abruptly reversed Read more
Omicron subvariants are now dominant in the U.S. as COVID cases tick up and New York City becomes a hot spot
Omicron subvariants continued to account for more new cases of COVID-19 in the U.S. in the latest week than did BA.5, according to the latest data from the Centers for Read more
BioVie Shares jump Premarket on Parkinson’s, Alzheimer’s Studies >BIVI
By Colin Kellaher Shares of BioVie Inc. rose sharply in premarket trading Tuesday after the clinical-stage biopharmaceutical company reported positive results from a pair of Phase 2 studies assessing the
The head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus pandemic as the country’s zero-COVID Read more Widespread protests across China over the government’s zero-COVID policy dominated pandemic headlines Monday, with Anthony Fauci, President Joe Biden’s chief medical adviser, weighing in with the view that the strategy does Read more The U.S. is unlikely to suffer the same surge of COVID-19 infections this winter as it did last year, when the omicron variant first emerged and swept across the country, Read more A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and German partner BioNTech said Friday. Read more If 80% of children ages 5 and older get their COVID booster shots by the end of 2022, it could prevent about 29 million missed days of school and almost Read more
IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderly
China’s zero-COVID strategy makes no sense and its homegrown vaccines are not ‘particularly effective,’ says Fauci
U.S. unlikely to see another late-year omicron wave, but Fauci urges people to get new COVID booster
Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
A robust booster campaign could prevent millions of missed school days among children ages 5 to 17, report finds